Strata Skin Sciences, Inc.
SSKN
$1.42
-$0.05-3.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.82M | -11.48M | -9.09M | -10.03M | -9.33M |
| Total Depreciation and Amortization | 4.88M | 5.24M | 5.27M | 5.31M | 5.36M |
| Total Amortization of Deferred Charges | 157.00K | 156.00K | 156.00K | 148.00K | 137.00K |
| Total Other Non-Cash Items | 3.68M | 4.15M | 4.05M | 4.13M | 3.01M |
| Change in Net Operating Assets | 257.00K | -160.00K | 56.00K | 630.00K | 1.68M |
| Cash from Operations | -1.85M | -2.09M | 442.00K | 188.00K | 856.00K |
| Capital Expenditure | -1.66M | -704.00K | -1.11M | -1.64M | -2.85M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.66M | -704.00K | -1.11M | -1.64M | -2.85M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.19M | 1.94M | 1.94M | 1.94M | 1.94M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -18.00K | -18.00K |
| Cash from Financing | 2.19M | 1.94M | 1.94M | 1.93M | 1.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.32M | -851.00K | 1.28M | 477.00K | -69.00K |